Meridian Clinical Research
Sioux City, Iowa, United States
Medical clinic in Sioux City, Iowa
4802 Sunnybrook Dr, Sioux City, IA 51106
About Meridian Clinical Research
"Meridian Clinical Research studies the safety and efficacy of new treatments. When people like you participate in clinical trials, we can uncover better ways to treat conditions that may affect you and your loved ones. Meridian's Sioux City site conducts research for a broad range of investigational treatments. Studies at this site explore vaccines and medicines developed to treat migraines, acne, depression, high cholesterol, and other conditions."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
8
ModernaTX, Inc.
7
Bavarian Nordic
2
BioNTech SE
2
Medicago
1
Novavax
1
Satsuma Pharmaceuticals, Inc.
1
Clinical Trials at Meridian Clinical Research
During the past decade, Meridian Clinical Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 2 clinical trials were completed, i.e. on
average, 9.1% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 2 clinical trials were completed. i.e. 10%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.
2017-04-24
2022-10-25
Completed
1,610
Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals
2020-04-29
2023-02-10
Completed
47,079
A Dose Escalation Study to Evaluate Safety, Reactogenicity, and Immunogenicity of mRNA-1345 in Healthy Adults and in Children Who Are Respiratory Syncytial Virus (RSV)-Seropositive
2020-09-30
2023-09-30
Active, not recruiting
651
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY
2021-01-06
2021-11-17
Completed
151
Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults
2020-11-19
2022-04-30
Active, not recruiting
30,918
Safety and Immunogenicity Study of 20vPnC in Healthy Children 15 Months Through 17 Years of Age
2020-12-04
2022-04-06
Completed
839
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
2021-01-15
2031-07-15
Recruiting
2,100
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Meridian Clinical Research" #1 sponsor was "Pfizer" with 8 trials, followed by "ModernaTX, Inc." with 7 trials
sponsored, "Bavarian Nordic" with 2 trials sponsored, "BioNTech SE" with 2 trials sponsored and "Medicago"
with 2 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Meridian Clinical Research"
#1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Meridian Clinical Research
According to Clinical.Site data, the most researched conditions in "Meridian Clinical Research" are
"SARS-CoV-2 Infection" (4 trials), "COVID-19" (3 trials), "Respiratory Syncytial Virus" (3 trials), "Seasonal Influenza" (3 trials) and "Migraine" (2 trials). Many other conditions were trialed in "Meridian Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Meridian Clinical Research
Most popular intervention types in "Meridian Clinical Research" are "Biological" (16 trials), "Drug" (7 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (11 trials), "mRNA-1010" (3 trials), "mRNA-1345" (3 trials), "Active Comparator" (2 trials) and "BNT162b2" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Meridian Clinical Research
The vast majority of trials in "Meridian Clinical Research" are
22 trials for "All" genders.
Clinical Trials Status at Meridian Clinical Research
Currently, there are NaN active trials in "Meridian Clinical Research".
undefined are not yet recruiting,
3 are recruiting,
9 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in Meridian Clinical Research,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Meridian Clinical Research, 5 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 15 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".